Production Cost Report
tanespimycin-e11a
magnesium-sulfate-e11a,riboflavin-e11a,paracetamol-e11a
Tanespimycin
Tanespimycin
Tanespimycin is a water-soluble benzoquinone antineoplastic antibiotic. It acts as an inhibitor of Hsp90, a heat shock protein that plays a central role in promoting the functionality and stability of a group of proteins associated with cancer. Tanespimycin is a derivative of geldanamycin, an antibiotic that is being studied in the treatment of cancer and patients with certain types of leukemia or solid tumors, especially kidney tumors.

Tanespimycin Production Cost Reports - Q2 2019

Capital Investment & Operating Cost of Tanespimycin Plants

Tanespimycin is a water-soluble benzoquinone antineoplastic antibiotic. It acts as an inhibitor of Hsp90, a heat shock protein that plays a central role in promoting the functionality and stability of a group of proteins associated with cancer. Tanespimycin is a derivative of geldanamycin, an antibiotic that is being studied in the treatment of cancer and patients with certain types of leukemia or solid tumors, especially kidney tumors.

Intratec offers professional, easy-to-understand reports examining Tanespimycin production. Each study describes an industrial plant, including main process units and site infrastructure, and presents an independent analysis of capital and operating costs. All reports are based on the most recent economic data available (Q2 2019).

You can find below reports focused on Tanespimycin production processes currently offered by Intratec. If none of the off-the-shelf reports listed below fits your needs, you can request a bespoke report tailored to your needs, for as low as USD 2,900!

Tanespimycin Production from Corn - Cost Analysis | Tanespimycin E11A

This report presents the economics of the production of Tanespimycin production from corn in the USA, via a typical fermentation process. Initially, corn starch is converted to glucose by alplha amylase. The glucose generated is then fermented to geldanamycin. Finally, geldanamycin is converted to Tanespimycin.

Details: 0 kta United States-based plant   |   Q2 2019   |   106 pages   From $1,999

The cost analyses presented in the report Tanespimycin E11A target a 0 kta (kilometric tons per annun) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.

Could Not Find the Report you Need?

If none of the Tanespimycin reports listed above fits your needs, you can request a bespoke report examining the process you are interested in! You will have a report tailored to your needs, in which you defined production process, industrial plant capacity and location!

Details: Customer-defined Plant Location & Capacity  |   Q2 2019 From $2,900

Customers Who Bought This Report Also Bought

Magnesium Sulfate Production Process - Cost Analysis | Magnesium Sulfate E11A

This report analyses the economics of a Magnesium Sulfate production process from magnesium carbonate and sulfuric acid in the USA. In this process, magnesium carbonate is treated with sulfuric acid, yielding magnesium sulfate,

Details: 150 kta United States-based plant   |   Q2 2019   |   106 pages From $999

The cost analyses presented in the report Magnesium Sulfate E11A target a 150 kta (kilometric tons per annun) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.

Paracetamol Production from p-Nitrochlorobenzene - Cost Analysis | Paracetamol E11A

This report analyses the economics of Paracetamol production from 4-nitrochlorobenzene, sodium hydroxide, hydrogen and acetic anhydride in the USA. In the process, 4-nitrochlorobenzene reacts with sodium hydroxide producing para nitro phenol (PNP). The PNP is then subjected to reduction, producing para amino phenol (PAP). The PAP is then acetylated to produce Paracetamol.

This report is also available in report subscriptions offered by Intratec.

Details: 4.80 kta United States-based plant   |   Q2 2019   |   107 pages From $1,999

The cost analyses presented in the report Paracetamol E11A target a 4.80 kta (kilometric tons per annun) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.

Riboflavin Production from Glucose - Cost Analysis | Riboflavin E11A

This report presents the economics of Riboflavin production from glucose in the USA, via a typical direct fermentation process.

Details: 1 kta United States-based plant   |   Q2 2019   |   106 pages From $1,999

The cost analyses presented in the report Riboflavin E11A target a 1 kta (kilometric tons per annun) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.

Use our Reports as

Feasibility Studies

Techno-economic Evaluations

Investment Analyses

Multi-regional Cost Analyses

Trusted By

BASF
Monsanto
Linde